Skip to main content

Table 2 Baseline characteristics of patients who presented for operation for POP–Q II–III and genuine SUI between January 2006 and December 2012

From: Does anchoring vaginal mesh increase the potential for correcting stress incontinence?

 

Modified TVM group (N = 62)

Control group I (historical controls: TVM) (N = 62)

Control group II (historical controls: anterior colporrhaphy) (N = 124)

p value

Age (y) (mean ± S.D.)

62.9 ± 7.7

59.7 ± 10.1

55.9 ± 11.1

< 0.001

BMI (kg/m2) (mean ± S.D.)

29.4 ± 2.9

28.4 ± 3.0

27.8 ± 3.8

0.004

Previous vaginal deliveries (mean ± S.D.)

2.3 ± 1.2

2.1 ± 0.6

2.1 ± 0.8

0.71

Postmenopausal women, n (%)

60 (96.8)

47(75.8)

92 (74.2)

0.001

Previous vaginal operations, n (%)

24 (38.7)

14 (22.6)

36 (29.0)

0.14

Chronic systemic diseases, n (%)

17 (27.4)

16 (25.8)

18 (14.5)

0.06

Diabetes mellitus, n (%)

10 (16.1)

10 (16.1)

9 (7.3)

0.09

Autoimmune diseases, n (%)

4 (6.5)

3 (4.8)

5 (4.0)

0.77

Airway diseases, n (%)

5 (8.1)

3 (4.8)

6 (4.8)

0.64

  1. All recruited patients presented for anterior compartment POP–Q II–III (pelvic organ prolapse) and genuine SUI (stress urinary incontinence). The modified transvaginal mesh (mTVM) group comprised patients who received a four–arm mesh that was fixed to the mid-urethra. Control groups I and II include historical controls who had participated in TVM and anterior colporrhaphy without any Kelly–Stoeckel suture, respectively
  2. Chronic systemic diseases include diabetes mellitus, airway diseases and autoimmune diseases